AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
VaxImmune vaccine adjuvant licensed to Chiron.
2004 JAN 21 - (NewsRx.com & NewsRx.net) -- Coley Pharmaceutical Group, Inc., announced that Chiron Corporation has licensed Coley's proprietary VaxImmune vaccine adjuvant for incorporation into multiple vaccine candidates.
Under the terms of the agreement, Chiron receives a worldwide non-exclusive license to VaxImmune, a powerful synthetic CpG vaccine adjuvant, for use in certain prophylactic infectious disease vaccine fields. Coley will receive upfront license fees and development milestones. In addition, Coley will receive royalties from sales of products developed subject to the license. Further terms were not disclosed.
"This agreement with a leading vaccine developer further demonstrates the value of our CpG adjuvant technology to enhance the performance of both prophylactic and therapeutic vaccines. I am delighted that Chiron has made VaxImmune a part of their adjuvant strategy for the next generation of infectious disease vaccines," said Robert L. Bratzler, PhD, president and CEO of Coley Pharmaceutical Group. "Our collaboration with Chiron further advances our strategy to license Coley's ...
- VaxImmune vaccine adjuvant licensed to Chiron.
- Newspaper article from: Drug Week January 23, 2004 700+ words
...licensed Coley's proprietary VaxImmune vaccine adjuvant for incorporation into multiple...researchers have demonstrated that VaxImmune vaccine adjuvants are suitable for...licensing and development of its VaxImmune vaccine adjuvant products. In addition to...
- Coley Pharmaceutical amends strategic alliance licence agreement with...
- News wire article from: Chemical Business Newsbase December 8, 2006 700+ words
...GlaxoSmithKline (GSK) for the use of Coley's VaxImmune vaccine adjuvant product in the development of certain infectious...licence for the use of Coley's proprietary VaxImmune vaccine adjuvant compound in certain therapeutic and prophylactic...
- Coley Pharmaceutical Group licenses VaxImmune vaccine adjuvant to Chiron Corp...
- News wire article from: Asia Africa Intelligence Wire December 23, 2003 700+ words
...licensed Coley Pharmaceuticals' proprietary VaxImmune vaccine adjuvant for incorporation into multiple vaccine candidates...licence to VaxImmune, a powerful synthetic CpG vaccine adjuvant, for use in certain prophylactic infectious...
- Coley Pharmaceutical Amends Strategic Alliance License Agreement With...
- Press release article from: PR Newswire December 8, 2006 700+ words
...Coley's VaxImmune(TM) vaccine adjuvant product in the development...of Coley's proprietary VaxImmune vaccine adjuvant compound in certain therapeutic...interested in leveraging the vaccine adjuvant in the development of prophylactic...
- BioSante Pharmaceuticals Announces Publication of Data for CAP Vaccine Adjuvant.
- Press release article from: PR Newswire November 6, 2000 700+ words
...announced that data pertaining to its CAP vaccine adjuvant have been published in the November...proprietary calcium phosphate-based vaccine adjuvant and delivery system (CAP). "The...CAP's great potential for use as a vaccine adjuvant in humans," said Stephen M. Simes...
- Vaccine adjuvant vector, CTA1-DD/ISCOM, designed.
- Newspaper article from: Biotech Business Week February 9, 2004 700+ words
...scientists reports the rational design of a vaccine adjuvant vector, CTA1-DD/ISCOM, in a...a strategy to rationally design a vaccine adjuvant vector that fulfils the criteria of...ISCOMs into a new highly promising vaccine adjuvant vector, CTA1-DD/ISCOMs," said...
- Coley Pharmaceutical Group Licenses VaxImmune(TM) Vaccine Adjuvant to Chiron...
- Press release article from: PR Newswire December 23, 2003 700+ words
...Coley's proprietary VaxImmune(TM) vaccine adjuvant for incorporation into multiple vaccine...TM), a powerful synthetic CpG vaccine adjuvant, for use in certain prophylactic...our strategy to license Coley's vaccine adjuvant technology for important applications...
- Novel monoclonal antibody-based vaccine adjuvant found to significantly enhance...
- Newspaper article from: AIDS Weekly June 29, 1992 700+ words
Italy A novel vaccine adjuvant employing a monoclonal antibody...proprietary Trigger antibody as a vaccine adjuvant," said Donald L. Drakeman...of Medarex. "We believe our vaccine adjuvant could improve the efficacy of...
- MedImmune And Chiron Enter Agreement On Vaccine Adjuvant Technology; Chiron to...
- Press release article from: Business Wire September 14, 1998 700+ words
...have entered into an agreement on vaccine adjuvant technology developed by Chiron. Under...MedImmune with MF59, a proprietary vaccine adjuvant, for two of MedImmune's vaccine...efforts to commercialize an improved vaccine adjuvant and look forward to working with them...
- CTA1-DD vaccine adjuvant potentiates human B cell stimulating ability.
- Newspaper article from: Health & Medicine Week February 23, 2004 700+ words
...NewsRx.net) -- The CTA1-DD vaccine adjuvant binds to human B cells and potentiates...their study in Vaccine (The CTA1-DD vaccine adjuvant binds to human B cells and potentiates...comes under the major subject areas of Vaccine Adjuvant, Vaccine Development, Immunology...
Source: HighBeam Research, VaxImmune vaccine adjuvant licensed to Chiron.